Suxibuzone

DB13232

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 438.473
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Suxibuzone may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Suxibuzone.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Suxibuzone.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Suxibuzone.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Suxibuzone.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Suxibuzone.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Suxibuzone.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Suxibuzone.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Suxibuzone.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Suxibuzone.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Suxibuzone.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Suxibuzone.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Suxibuzone.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Suxibuzone.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Suxibuzone.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Suxibuzone.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Suxibuzone.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Suxibuzone.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Suxibuzone.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Suxibuzone.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Suxibuzone.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Suxibuzone.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Suxibuzone.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Suxibuzone.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Suxibuzone.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Suxibuzone.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Suxibuzone.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Suxibuzone.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Suxibuzone.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Suxibuzone.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Suxibuzone.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Suxibuzone.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Suxibuzone.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Suxibuzone.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Suxibuzone.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Suxibuzone.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Suxibuzone.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Suxibuzone.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Suxibuzone.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Suxibuzone.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Suxibuzone.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Suxibuzone.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Suxibuzone.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Suxibuzone.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Suxibuzone.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Suxibuzone.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Suxibuzone.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Suxibuzone.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Suxibuzone.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Suxibuzone.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Suxibuzone.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Suxibuzone.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Suxibuzone.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Suxibuzone.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Suxibuzone.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Suxibuzone.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Suxibuzone.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Suxibuzone.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Suxibuzone.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Suxibuzone.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Suxibuzone.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Suxibuzone.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Suxibuzone.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Suxibuzone.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Suxibuzone.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Suxibuzone.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Suxibuzone.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Suxibuzone.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Suxibuzone.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Suxibuzone.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Suxibuzone.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Suxibuzone.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Suxibuzone.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Suxibuzone.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Suxibuzone.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Suxibuzone.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Suxibuzone.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Suxibuzone.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Suxibuzone.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Suxibuzone.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Suxibuzone.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Suxibuzone.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Suxibuzone.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Suxibuzone.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Suxibuzone.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Suxibuzone.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Suxibuzone.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Suxibuzone.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Suxibuzone.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Suxibuzone.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Suxibuzone.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Suxibuzone.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Suxibuzone.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Suxibuzone.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Suxibuzone.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Suxibuzone.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Suxibuzone.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Suxibuzone.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Suxibuzone.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Suxibuzone.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul